首页> 外文期刊>European journal of pain : >Evolution of a rational use of opioids in chronic pain.
【24h】

Evolution of a rational use of opioids in chronic pain.

机译:在慢性疼痛中合理使用阿片类药物的演变。

获取原文
获取原文并翻译 | 示例
           

摘要

Since the isolation of morphine from opium by Serturner in 1806, morphine, which Osler referred to as "God's own medicine", has remained the analgesic of choice for the treatment of severe pain despite its known addictive potential and the attempts to replace it with synthetic or semi-synthetic medications. Its early use was based on clinical experience alone until the identification of the opioid receptors and endogenous opioids 25 years ago. Advances in pharmacology and pharmacokinetics and the development of precision equipment to quantify the parent drugs and their metabolites in plasma have provided a better understanding of the mechanisms of action as well as adverse effects. Clinicians can now select the drug and route of administration to suit the patient's needs. The objective of care now is for clinical observation to be reinforced by randomized controlled trials and evidence-based medicine, but controlled clinical trials are lacking for the use of opioids in chronic pain.
机译:自1806年由瑟特纳(Serturner)从鸦片中分离出吗啡以来,尽管它具有令人上瘾的成瘾潜力,并且试图用合成的多酚来替代,但奥斯勒将吗啡称为“上帝自己的药物”,仍然是治疗剧烈疼痛的首选镇痛药或半合成药物。它的早期使用仅基于临床经验,直到25年前才确定了阿片受体和内源性阿片类药物。药理学和药代动力学的进展以及对血浆中母体药物及其代谢产物进行定量分析的精密设备的发展,使人们对作用机理以及不良反应有了更好的了解。临床医生现在可以选择药物和给药途径来满足患者的需求。现在,护理的目的是通过随机对照试验和循证医学来加强临床观察,但是缺乏在慢性疼痛中使用阿片类药物的对照临床试验。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号